Press "Enter" to skip to content

Screen for Cyberbullying; Rexulti for Alzheimer’s Agitation? Schizophrenia Tx Flops

When assessing a child’s suicide risk, clinicians should ask about cyberbullying experiences, which was an even stronger prediction of suicide than being a target of offline peer aggression. (JAMA Network Open)

Even after a child’s first birthday, both parents should be screened for mental health issues in the pediatric office, researchers suggested. “The current American Academy of Pediatrics guidelines only recommend that pediatric clinicians screen for maternal depression in the first year of their infant’s life,” said lead author Ava Marie Hunt, MD, of Children’s Hospital of Philadelphia. (Pediatrics)

Otsuka Pharmaceutical and H. Lundbeck announced positive phase III trial results of brexpiprazole (Rexulti) for the treatment of agitation in patients with Alzheimer’s dementia.

According to a meta-analysis of 98 trials, continuing antipsychotic treatment at standard doses was just as effective as switching to a different antipsychotic. (The Lancet Psychiatry)

Roche reportedly threw in the towel on two failed phase II trials of investigational agent ralmitaront for the treatment of schizophrenia. (Endpoints News)

Kids conceived via medically assisted reproduction, like IVF, were more likely to face mental health issues as teenagers. “The fact that we observe an increased risk of mental health disorders once we account for family characteristics could be a cause for concern and merits further attention in future research,” said Alice Goisis, PhD, of the University College London Centre for Longitudinal Studies. (European Journal of Population)

As THC levels continue to rise in cannabis products like vapes, more and more teens are getting seriously sick. (New York Times)

The Biden administration announced plans to expand telehealth access for addiction treatment services.

University of California San Francisco’s new psychiatry building opened its doors this week, with a mission to redefine the environment for mental health services.

  • Kristen Monaco is a staff writer, focusing on endocrinology, psychiatry, and nephrology news. Based out of the New York City office, she’s worked at the company since 2015.

Please enable JavaScript to view the comments powered by Disqus.

Source: MedicalNewsToday.com